Form 4: Surrozen CFO and COO, Charles O. Williams, Acquires 45,000 Stock Options

Charles O. Williams, CFO and COO of Surrozen, Inc., acquired 45,000 stock options on January 17, 2025, which vest monthly starting February 1, 2025.

Summary

• Charles O. Williams, the CFO and COO of Surrozen, Inc., has reported a transaction involving the acquisition of stock options.
• On January 17, 2025, Mr. Williams acquired 45,000 stock options with an exercise price of $12.08 per share.
• These options vest in 48 equal monthly installments beginning on February 1, 2025, contingent upon his continued service with the company.
• The options expire on January 17, 2035.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management's interests with shareholders. There are no negative implications.

Positives

• The acquisition of stock options by a key executive like the CFO and COO can be seen as a positive sign of their confidence in the company's future performance.

Future Outlook

The vesting of the options is contingent on the reporting person's continuous service, suggesting a long-term commitment from the executive.

Industry Context

This is a standard practice for executive compensation in publicly traded companies, aligning management's interests with those of shareholders.

Comparison to Industry Standards

• Stock option grants are a common form of compensation for executives in the biotechnology industry, similar to practices at companies like Amgen, Regeneron, and Gilead Sciences.
• The vesting schedule of 48 months is also typical, designed to incentivize long-term performance and retention.

Stakeholder Impact

• The stock option grant could positively impact shareholder confidence by demonstrating the executive's commitment to the company's long-term success.

Key Dates

Keywords

stock options, insider trading, executive compensation, Surrozen, SRZN, Charles O. Williams, CFO, COO